Prof. Amos Olalekan
Abolaji
Professor of Molecular Drug Metabolism and Toxicology, University of Ibadan
I use the fruit fly to work out how drugs and environmental toxins drive Parkinson's disease, cancer and reproductive harm, and which natural compounds can protect against them.
97 peer-reviewed papers and chapters, cited 3,613 times. h-index 32 on Google Scholar, August 2026.

A fly lab in Ibadan with partners on five continents
In 2014 Prof. Abolaji set up the first Drosophila laboratory in the Department of Biochemistry at the University of Ibadan. The fruit fly shares most of its disease genes with people, breeds in days and costs little to keep, which makes it a powerful way to do world-class biomedical research where resources are tight.
His group uses it to trace how environmental chemicals and drugs damage cells, and to test plant compounds that protect against that damage. The work has trained researchers from 21 Nigerian institutions and more than 140 students.
From exposure to rescue
A fly's eye is a living readout
What the eye shows: A healthy eye: every facet the same size, glossy and in perfect rows.
1Exposure
What the eye shows: Gold particles drift in from the edges and are absorbed: the toxicant arriving.
2Oxidative stress
What the eye shows: White sparks flicker across the facets: bursts of reactive oxygen species.
3Degeneration
What the eye shows: Facets darken, shrink and slip out of line. This is what biologists call a rough eye.
4Rescue
What the eye shows: Order and shine return across the lattice as the protective compound takes effect.
Research themes
Six lines of work, all built on the same question: how does a chemical exposure become a disease, and can it be stopped?
The fruit fly as a model for toxicology
Establishing Drosophila melanogaster as a low-cost, genetically tractable model for toxicology and biomedical research in Africa, from survival and climbing assays to redox biochemistry, gene expression and transcriptomics.
Neurodegeneration and Parkinson's disease
Modelling Parkinson's disease with neurotoxins and genetic lines such as parkin and α-synuclein flies, and testing dietary phytochemicals that protect dopaminergic neurons through antioxidant and mitochondrial actions.
Cancer: carcinogens and personalised fly avatars
Defining how chemical carcinogens disrupt redox balance and gene expression, and, with the University of Glasgow, building Drosophila avatars that carry the tumour mutations of individual African colorectal cancer patients to screen drugs in vivo.
Reproductive and endocrine toxicology
Investigating chemicals and drugs that damage the ovary, uterus and testis, including the industrial ovotoxicant 4-vinylcyclohexene and its metabolites and the safety of artemisinin-based antimalarials in pregnancy.
Metals, nicotine and everyday chemicals
Tracing the toxicity of heavy metals, e-cigarettes, micro- and nanoplastics, pesticides and food additives, and evaluating chelators and natural products that counter them.
Metabolism, diabetes and ageing
Using high-sucrose diets and ageing models in flies to study diabetes-like hyperglycaemia, cognitive decline and lifespan, and the peptides and plant extracts that modify them.
Where the work happens
Training in Ile-Ife, Lagos, Calabar, Karachi and Santa Maria. Partnerships today with Glasgow, Harvard, Oxford and the ICGEB in Trieste.
Building a New Generation of Cancer Therapies
University of Glasgow / Pershing Square Foundation, 2022–2027
FLY-NEUROCAN Workshop: Frontiers in Drosophila Research for Neurodegeneration and Cancer
Cambridge-Africa ALBORADA Research Fund, ICGEB and the Company of Biologists, 2025–2026
Discovering the Molecular Mechanisms Underlying Toxicity of Environmental Pollutants in Nigeria
Motsepe Foundation / Harvard University, 2023–2025
Collaborations, postgraduate study and speaking invitations
Prospective students and research partners are welcome to get in touch.